Working... Menu

Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00658086
Recruitment Status : Completed
First Posted : April 14, 2008
Last Update Posted : January 29, 2018
Information provided by:
Alnylam Pharmaceuticals

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2009
  Actual Study Completion Date : June 2009
  Certification/Extension First Submitted : January 24, 2018